Nicola has 25 years of experience in vaccine development with considerable expertise in influenza vaccines. Through her various strategic positions in the industry, she has developed expertise throughout the vaccine lifecycle, including close and extensive interactions with regulatory agencies.

Prior Experience:
• Global Head of Safety Evaluation & Risk Management, GlaxoSmithKline (GSK) Vaccines, Siena (2015-2023)
• Global Head Clinical Trial Serious Adverse Event Management, Novartis Vaccines and Diagnostics, Siena (2013-2015)
• Senior Epidemiologist, Novartis Vaccines and Diagnostics, Siena (2010-2013)
• Global Lead Influenza Vaccines, Medical Affairs, Novartis Vaccines and Diagnostics, Siena (2009-2010)
• Global Head Clinical Influenza Vaccine Development, Novartis Vaccines and Diagnostics, Siena (2006-2009)
• Clinical Team Leader, Chiron Corporation, Siena (2003-2006)
• Medical Monitor, Clinical Research and Development, Chiron Corporation, Siena (2001-2002)

Education:
• Doctor of Medicine from Siena University
• PhD in Hygiene and Preventive Medicine from Siena University